Compare VOC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | MYO |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1M | 63.8M |
| IPO Year | N/A | 2017 |
| Metric | VOC | MYO |
|---|---|---|
| Price | $2.96 | $0.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.64 |
| AVG Volume (30 Days) | 139.5K | ★ 244.1K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | ★ 14.81% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | $334.12 | $13.25 |
| Revenue Next Year | N/A | $10.45 |
| P/E Ratio | $6.00 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $2.63 | $0.61 |
| 52 Week High | $3.84 | $1.89 |
| Indicator | VOC | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 34.69 | 31.16 |
| Support Level | $2.80 | $0.67 |
| Resistance Level | $3.40 | $0.95 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 25.64 | 4.97 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust. It operates in a single operating and reportable segment.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.